Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent phyllodes tumor in a man

Z Kahán1, A M Tószegi, F Szarvas

  • 1Department of Oncotherapy, Albert Szent-Györgyi Medical University, Szeged, Hungary.

Pathology, Research and Practice
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Adenomatous leydig cell hyperplasia of the testicle remnant after subtotal orchidectomy in the rat.

Endocrine pathology·2020
Same author

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.

British journal of cancer·2014
Same author

The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer.

Neoplasma·2012
Same journal

A novel oxygen-releasing bilayer delivery system for cell survival and peripheral nerve regeneration.

Pathology, research and practice·2026
Same journal

Autophagy modulation in ulcerative colitis with traditional Chinese medicine: A review.

Pathology, research and practice·2026
Same journal

Ras signalling in infectious disease pathology: Mechanisms, tissue damage, and clinical implications.

Pathology, research and practice·2026
Same journal

CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.

Pathology, research and practice·2026
Same journal

Multifactorial pathophysiology of varicocele: Integrating hemodynamic, oxidative, and endocrine mechanisms.

Pathology, research and practice·2026
Same journal

Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives.

Pathology, research and practice·2026
See all related articles

A borderline cystosarcoma phyllodes case showed no relapse after surgery and radiotherapy. A slight increase in SHBG, possibly linked to liver disease, reduced bioavailable androgens.

Area of Science:

  • Oncology
  • Endocrinology
  • Pathology

Background:

  • Presents a rare case of borderline-type cystosarcoma phyllodes in a 35-year-old male.
  • Highlights the management of local recurrence including wide excision and radiotherapy.

Observation:

  • The patient experienced no relapse during a 5-year follow-up period post-treatment.
  • No significant endocrine changes or genetic alterations were identified.
  • A slight increase in Sex Hormone-Binding Globulin (SHBG) concentration was noted, leading to reduced bioavailable androgens and a lower testosterone/SHBG index.

Findings:

  • The observed SHBG elevation may be associated with the patient's chronic liver disease, stemming from type II diabetes mellitus and alcohol abuse.
  • Advanced investigations included histopathology, immunohistochemistry, electron microscopy, and analysis of steroid receptors, EGF receptors, and EGF-like activity.

Related Experiment Videos

Implications:

  • This case underscores the importance of long-term follow-up for cystosarcoma phyllodes.
  • Suggests a potential link between chronic liver disease, altered androgen levels, and tumor behavior, warranting further investigation.
  • Emphasizes the utility of comprehensive histopathological and molecular analyses in understanding rare tumor entities.